Orthostatic Hypertension: Critical Appraisal of an Overlooked Condition.
Adrenergic Neurons
/ physiology
Antihypertensive Agents
/ therapeutic use
Autonomic Nervous System
/ physiopathology
Baroreflex
/ physiology
Disease Progression
Heart Conduction System
/ physiopathology
Humans
Hypertension
/ drug therapy
Hypotension, Orthostatic
/ diagnosis
Norepinephrine
/ physiology
Posture
Prevalence
Tilt-Table Test
Vascular Resistance
Vestibule, Labyrinth
/ physiopathology
baroreflex
blood pressure
cardiovascular system
orthostatic hypertension
standing position
Journal
Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
1
4
2020
medline:
7
4
2021
entrez:
1
4
2020
Statut:
ppublish
Résumé
Orthostatic hypertension, which appears to be mediated through excess neurohumoral activation while standing, is a common blood pressure trait among patients with and without arterial hypertension. However, lack of consensus regarding the definition of orthostatic hypertension makes it difficult to assess the true prevalence of this condition. Orthostatic hypertension appears to predict the risk for progression to arterial hypertension in younger and risk of cardiovascular morbidity and mortality in older persons. Yet, the risk may differ between populations. Whether orthostatic hypertension indicates a generally increased risk of death, constitutes an intermediate variable in the causal pathway of cardiovascular risk factors, a simple measure of disease severity, or an independently acting mechanism is not known. Since both orthostatic hypotension and orthostatic hypertension herald increased risk of cardiovascular disease, it appears reasonable to screen the patients for abnormal orthostatic blood pressure responses using simple orthostatic testing. However, how presence of orthostatic hypertension may affect clinical management decisions such as the choice of antihypertensive drugs is currently difficult to ascertain. Clearly, this issue deserves more attention.
Identifiants
pubmed: 32223382
doi: 10.1161/HYPERTENSIONAHA.120.14340
doi:
Substances chimiques
Antihypertensive Agents
0
Norepinephrine
X4W3ENH1CV
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM